Contact details

Name: Milan Rudic

Job title: Consultant ENT Surgeon

Location: Stockport NHS Foundation Trust

Email: milan.rudic@stockport.nhs.uk

Specialities and research

Speciality

• Otolaryngology    

Research interests

• Otolaryngology 
• Hearing loss 

Type of research

• Audit 
• Clinical trials  
• Research for patient benefit 

Clinical trial experience

Chief investigator 

• OSTRICH:  Oral Steroids for the resolution of otitis media with effusion (OME) in children. 
• SINUS-24: A controlled clinical study of Dupilumab in patients with bilateral nasal polyposis.  
• COV-Boost: Evaluating COVID-19 vaccine boosters – A randomised phase II UK multi-centre study to determine reactogenicity and immunogenicity of booster vaccination against ancestral and novel variants of SARS-CoV-2.   

Co-investigator

• Novavax 2019nCoV-302 – A phase III, randomised, observer-blinded, placebo–controlled trial to evaluate the efficacy and safety of a SARS-COV-2 recombinant spike protein nanoparticle vaccine (SARS-COV-2 RS) with Matrix-M1 TM adjuvant in 18 to 84-year-olds in the UK.  

Principal investigator

• WAYPOINT – A multicentre, randomised, double-blind, parallel-group, placebo-controlled phase 3 efficacy and safety study of Tezepelumab in participants with severe chronic rhinosinusitis with nasal polyposis. 

Postgraduate supervision

Milan is currently a PhD/MD supervisor. 

Related